IL6 and atherosclerosis: A cross-sectional data analysis from the Diet and Omega-3 Intervention Trial on Atherosclerosis (DOIT) showed that serum levels of IL-6 were significantly higher in subjects with MetS compared to those without MetS, but there was no significant association between IL-6 and increasing MetS components [10].